Inventor
AZNAREZ ISABEL
US13 patents
⚠️ This page may combine multiple inventors who share the name “AZNAREZ ISABEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
STOKE THERAPEUTICS INC
8 patentsUS11096956B2Aug 24, 2021
Antisense oligomers and uses thereof
STOKE THERAPEUTICS INC11 citations83
US10913947B2Feb 9, 2021
Antisense oligomers for treatment of conditions and diseases
STOKE THERAPEUTICS INC6 citations80
US10683503B2Jun 16, 2020
Antisense oligomers for treatment of conditions and diseases
STOKE THERAPEUTICS INC6 citations80
US11873490B2Jan 16, 2024
Antisense oligomers for treatment of conditions and diseases
STOKE THERAPEUTICS INC2 citations69
US12577561B2Mar 17, 2026
Antisense oligomers for treatment of conditions and diseases
STOKE THERAPEUTICS INC0 citations60
US12338437B2Jun 24, 2025
OPA1 antisense oligomers for treatment of conditions and diseases
STOKE THERAPEUTICS INC0 citations57
US11814622B2Nov 14, 2023
OPA1 antisense oligomers for treatment of conditions and diseases
STOKE THERAPEUTICS INC1 citations57
US12060558B2Aug 13, 2024
Methods and compositions for treatment of cholesteryl ester storage disease
STOKE THERAPEUTICS INC0 citations50
COLD SPRING HARBOR LABORATORY
5 patentsUS9976143B2May 22, 2018
Targeted augmentation of nuclear gene output
COLD SPRING HARBOR LABORATORY25 citations92
US11083745B2Aug 10, 2021
Antisense oligomers for treatment of autosomal dominant mental retardation-5 and Dravet Syndrome
COLD SPRING HARBOR LABORATORY6 citations71
US10696969B2Jun 30, 2020
Targeted augmentation of nuclear gene output
COLD SPRING HARBOR LABORATORY4 citations71
US10647983B2May 12, 2020
Reducing nonsense-mediated mRNA decay
COLD SPRING HARBOR LABORATORY2 citations68
US11352624B2Jun 7, 2022
Reducing nonsense-mediated MRNA decay
COLD SPRING HARBOR LABORATORY1 citations57